Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

SHE:300573 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	19,481	12,229	22,715	11,076	11,263	7,612
Market Cap Growth	-9.21%	-46.16%	105.08%	-1.66%	47.96%	29.71%
Enterprise Value	19,235	11,973	22,352	10,579	11,226	7,679
Last Close Price	79.40	48.70	89.40	43.39	47.03	32.62
PE Ratio	30.23	36.17	94.63	52.33	57.85	86.52
PS Ratio	8.09	6.29	15.48	8.86	10.96	11.05
PB Ratio	10.49	7.68	13.44	7.14	8.38	10.97
P/TBV Ratio	11.38	8.38	14.09	7.27	8.52	11.56
P/FCF Ratio	47.58	56.03	408.51	-	53.15	543.47
P/OCF Ratio	30.64	29.33	71.53	38.69	36.69	62.32
EV/Sales Ratio	7.99	6.16	15.23	8.46	10.92	11.15
EV/EBITDA Ratio	21.95	23.95	65.68	35.59	37.73	48.73
EV/EBIT Ratio	25.04	29.32	85.99	45.76	46.72	68.51
EV/FCF Ratio	46.98	54.85	401.97	-	52.98	548.27
Debt / Equity Ratio	0.07	0.14	0.05	0.01	0.08	0.12
Debt / EBITDA Ratio	0.15	0.42	0.23	0.05	0.36	0.51
Debt / FCF Ratio	0.33	0.99	1.42	-	0.53	5.71
Asset Turnover	1.05	0.94	0.77	0.72	0.78	0.76
Inventory Turnover	2.96	2.93	2.64	2.52	2.85	2.54
Quick Ratio	1.51	1.41	2.83	4.69	3.23	0.94
Current Ratio	1.90	1.80	3.48	5.68	3.69	1.39
Return on Equity (ROE)	37.08%	20.59%	14.81%	14.62%	20.52%	14.73%
Return on Assets (ROA)	20.85%	12.30%	8.54%	8.33%	11.33%	7.71%
Return on Capital (ROIC)	24.84%	14.27%	9.74%	9.56%	13.47%	9.74%
Return on Capital Employed (ROCE)	40.00%	24.50%	14.70%	14.20%	16.90%	14.90%
Earnings Yield	3.32%	2.76%	1.06%	1.91%	1.73%	1.16%
FCF Yield	2.10%	1.79%	0.24%	-0.12%	1.88%	0.18%
Dividend Yield	1.34%	2.20%	2.11%	1.26%	0.50%	0.28%
Payout Ratio	68.05%	138.01%	74.36%	38.19%	24.21%	18.41%
Buyback Yield / Dilution	-0.66%	-0.70%	-0.96%	-7.45%	0.30%	-2.88%
Total Shareholder Return	0.67%	1.50%	1.15%	-6.19%	0.80%	-2.60%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.